265 related articles for article (PubMed ID: 33023310)
1. Assessing risk of future cardiovascular events, healthcare resource utilization and costs in patients with type 2 diabetes, prior cardiovascular disease and both.
Nguyen C; Luthra R; Kuti E; Willey VJ
Curr Med Res Opin; 2020 Dec; 36(12):1927-1938. PubMed ID: 33023310
[TBL] [Abstract][Full Text] [Related]
2. Impact of cardiovascular disease on health care economic burden and resource utilization: a retrospective cohort study in adults in the United States with type 2 diabetes with or without stroke, myocardial infarction, and peripheral arterial disease.
King A; Rajpura J; Liang Y; Paprocki Y; Uzoigwe C
Curr Med Res Opin; 2022 Nov; 38(11):1831-1840. PubMed ID: 36134459
[TBL] [Abstract][Full Text] [Related]
3. Health care resource utilization among patients with T2D and cardiovascular-, heart failure-, or renal-related hospitalizations.
Annavarapu S; Ghosh S; Li Y; Moretz C; Shetty S; Prewitt T
Am J Manag Care; 2020 Jun; 26(6):e166-e171. PubMed ID: 32549065
[TBL] [Abstract][Full Text] [Related]
4. Differences in All-Cause Health Care Utilization and Costs in a Type 2 Diabetes Mellitus Population with and Without a History of Cardiovascular Disease.
Mehta S; Ghosh S; Sander S; Kuti E; Mountford WK
J Manag Care Spec Pharm; 2018 Mar; 24(3):280-290. PubMed ID: 29485954
[TBL] [Abstract][Full Text] [Related]
5. Clinical and economic burden associated with cardiovascular events among patients with hyperlipidemia: a retrospective cohort study.
Fox KM; Wang L; Gandra SR; Quek RGW; Li L; Baser O
BMC Cardiovasc Disord; 2016 Jan; 16():13. PubMed ID: 26769473
[TBL] [Abstract][Full Text] [Related]
6. Cardiovascular event costs in patients with Type 2 diabetes mellitus.
Johnston SS; Sheehan JJ; Shah M; Cappell K; Princic N; Smith D; Kalsekar I
J Med Econ; 2015; 18(12):1032-40. PubMed ID: 26189723
[TBL] [Abstract][Full Text] [Related]
7. Cardiovascular event incidence and cost in type 2 diabetes mellitus: a Medicare claims-based actuarial analysis.
Fitch K; Engel T; Sander S; Kuti E; Blumen H
Curr Med Res Opin; 2017 Oct; 33(10):1795-1801. PubMed ID: 28641023
[TBL] [Abstract][Full Text] [Related]
8. Long-term cardiovascular risk and costs for myocardial infarction survivors in a US commercially insured population.
Kern DM; Mellström C; Hunt PR; Tunceli O; Wu B; Westergaard M; Hammar N
Curr Med Res Opin; 2016; 32(4):703-11. PubMed ID: 26709864
[TBL] [Abstract][Full Text] [Related]
9. Incremental burden of type 2 diabetes in patients experiencing cardiovascular hospitalizations.
Coutinho AD; Raju AD; Wang W; Stafkey-Mailey D; Shetty S; Sander SD
Curr Med Res Opin; 2018 Jun; 34(6):1005-1012. PubMed ID: 29378486
[TBL] [Abstract][Full Text] [Related]
10. Prevalence and incidence of cardiovascular and renal diseases in type 1 compared with type 2 diabetes: A nationwide French observational study of hospitalized patients.
Ducluzeau PH; Fauchier G; Herbert J; Semaan C; Halimi JM; Angoulvant D; Fauchier L
Diabetes Metab; 2023 May; 49(3):101429. PubMed ID: 36736892
[TBL] [Abstract][Full Text] [Related]
11. Longitudinal analysis of atherosclerotic cardiovascular disease risk and healthcare costs in newly diagnosed type 2 diabetes in a real-world setting.
Weng W; Liang Y; Brett J; Hobbs T; Baeres FMM
J Diabetes Complications; 2020 May; 34(5):107500. PubMed ID: 32173216
[TBL] [Abstract][Full Text] [Related]
12. Healthcare resource utilization and costs of cardiovascular events in patients with atherosclerotic cardiovascular disease in Germany - results of a claims database study.
Sidelnikov E; Dornstauder E; Jacob C; Maas C; Pinto L; Leidl R; Ahrens I
J Med Econ; 2022; 25(1):1199-1206. PubMed ID: 36330899
[TBL] [Abstract][Full Text] [Related]
13. Healthcare costs associated with cardiovascular events in patients with hyperlipidemia or prior cardiovascular events: estimates from Swedish population-based register data.
Hallberg S; Gandra SR; Fox KM; Mesterton J; Banefelt J; Johansson G; Levin LÅ; Sobocki P
Eur J Health Econ; 2016 Jun; 17(5):591-601. PubMed ID: 26077550
[TBL] [Abstract][Full Text] [Related]
14. Timing of randomization after an acute coronary syndrome in patients with type 2 diabetes mellitus.
Elharram M; Sharma A; White W; Bakris G; Rossignol P; Mehta C; Ferreira JP; Zannad F
Am Heart J; 2020 Nov; 229():40-51. PubMed ID: 32916607
[TBL] [Abstract][Full Text] [Related]
15. Fracture risk and healthcare resource utilization and costs among osteoporosis patients with type 2 diabetes mellitus and without diabetes mellitus in Japan: retrospective analysis of a hospital claims database.
Sato M; Ye W; Sugihara T; Isaka Y
BMC Musculoskelet Disord; 2016 Nov; 17(1):489. PubMed ID: 27887655
[TBL] [Abstract][Full Text] [Related]
16. Incremental cardiovascular costs and resource use associated with diabetes: an assessment of 29,863 patients in the US managed-care setting.
Straka RJ; Liu LZ; Girase PS; DeLorenzo A; Chapman RH
Cardiovasc Diabetol; 2009 Sep; 8():53. PubMed ID: 19781099
[TBL] [Abstract][Full Text] [Related]
17. Real-world comparison of hospitalization costs for heart failure in type 2 diabetes mellitus patients with established cardiovascular disease treated with canagliflozin versus other antihyperglycemic agents.
Chen YW; Voelker J; Tunceli O; Pericone CD; Bookhart B; Durkin M
J Med Econ; 2020 Apr; 23(4):401-406. PubMed ID: 31801393
[No Abstract] [Full Text] [Related]
18. The cost of cardiovascular-disease-related death in patients with type 2 diabetes mellitus.
Shetty S; Stafkey-Mailey D; Yue B; Coutinho AD; Wang W; Del Parigi A; Sander SD; Coleman CI
Curr Med Res Opin; 2018 Jun; 34(6):1081-1087. PubMed ID: 29480076
[TBL] [Abstract][Full Text] [Related]
19. Performance of the UKPDS Outcomes Model 2 for Predicting Death and Cardiovascular Events in Patients with Type 2 Diabetes Mellitus from a German Population-Based Cohort.
Laxy M; Schöning VM; Kurz C; Holle R; Peters A; Meisinger C; Rathmann W; Mühlenbruch K; Kähm K
Pharmacoeconomics; 2019 Dec; 37(12):1485-1494. PubMed ID: 31350720
[TBL] [Abstract][Full Text] [Related]
20. Incremental cost burden to US healthcare payers of atrial fibrillation/atrial flutter patients with additional risk factors.
Amin AN; Jhaveri M; Lin J
Adv Ther; 2011 Oct; 28(10):907-26. PubMed ID: 21971681
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
